{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:48Z","timestamp":1792182348536,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"U. S. Department of Energy, Office of Biological and Environmental Research","award":["DE-AC02-98CH10886"],"award-info":[{"award-number":["DE-AC02-98CH10886"]}]},{"name":"NIH Intramural Program of the National Institute on Alcohol Abuse and Alcoholism","award":["1R01DA030321"],"award-info":[{"award-number":["1R01DA030321"]}]},{"name":"BNL Science Undergraduate Laboratory Internship Program"},{"name":"Deutscher Akademischer Austauschdienst (DAAD)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.nucmedbio.2013.06.007","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T21:47:08Z","timestamp":1375134428000},"page":"912-918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET"],"prefix":"10.1016","volume":"40","author":[{"given":"Sung Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Hooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaing","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Muench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payton","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia E.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna S.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0005","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania","volume":"67","author":"Bowden","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":"Depletion of latent HIV-1 infection in vivo: a proof-of-concept study","volume":"366","author":"Lehrman","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2005.06.009","article-title":"Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release","volume":"1052","author":"Ichikawa","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pbc.21104","article-title":"Pulsed-dosing with oral sodium phenylbutyrate increases hemoglobin F in a patient with sickle cell anemia","volume":"50","author":"Hines","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199301143280202","article-title":"A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders","volume":"328","author":"Perrine","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0030","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V90.2.891","article-title":"Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease","volume":"90","author":"Selby","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2407-10-387","article-title":"Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients","volume":"10","author":"Advani","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0040","first-page":"67","article-title":"Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders","volume":"16","author":"Perrine","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJM199208203270818","article-title":"Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate","volume":"327","author":"Dover","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0050","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood.V84.5.1690.1690","article-title":"Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy","volume":"84","author":"Collins","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gut.34.3.386","article-title":"Butyrate production from dietary fibre and protection against large bowel cancer in a rat model","volume":"34","author":"McIntyre","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0060","first-page":"4720","article-title":"Enhancement of interferon antitumor action by sodium butyrate","volume":"39","author":"Bourgeade","year":"1979","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0065","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-10-1062","article-title":"Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response","volume":"10","author":"Kato","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0070","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/mt.2008.155","article-title":"Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses","volume":"16","author":"Otsuki","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1158\/1940-6207.CAPR-08-0142","article-title":"3,3\u2032-Diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin","volume":"2","author":"Bhatnagar","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0080","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1200\/JCO.2005.07.450","article-title":"Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignancies","volume":"23","author":"Rudek","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0085","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdermsci.2011.08.007","article-title":"Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling","volume":"64","author":"Chung","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0095","first-page":"1795","article-title":"Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo","volume":"25","author":"Michaelis","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17482960802320487","article-title":"Phase 2 study of sodium phenylbutyrate in ALS","volume":"10","author":"Cudkowicz","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0115","article-title":"Drug treatment for spinal muscular atrophy types II and III","volume":"12","author":"Wadman","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/157015911795017317","article-title":"The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats","volume":"9","author":"Romieu","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0125","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0130","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00003088-200746040-00004","article-title":"Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury","volume":"46","author":"Anderson","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0140","article-title":"Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults","volume":"10","author":"Gill","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0145","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.clnu.2010.04.002","article-title":"Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission","volume":"29","author":"Hamer","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0016-5085(92)91094-K","article-title":"Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis","volume":"103","author":"Scheppach","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0155","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors","volume":"409","author":"Khan","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/268462a0","article-title":"n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells","volume":"268","author":"Riggs","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbr.2011.03.033","article-title":"Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats","volume":"221","author":"Reolon","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1471-4159.2010.07149.x","article-title":"Histone deacetylase inhibition decreases preference without affecting aversion for nicotine","volume":"116","author":"Bernabeu","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/(SICI)1099-1344(199706)39:6<509::AID-JLCR996>3.0.CO;2-H","article-title":"Synthesis of saturated fatty acids C-11 (C-13)-labelled in the omega-methyl position","volume":"39","author":"Neu","year":"1997","journal-title":"J Labelled Compd Radiol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nucmedbio.2008.12.013","article-title":"Reinvestigation of the synthesis and evaluation of N-methyl-(11)C vorozole, a radiotracer targeting cytochrome P450 aromatase","volume":"36","author":"Kim","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0920-1211(02)00251-6","article-title":"Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy","volume":"53","author":"Cloyd","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0190","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0277-5379(87)90109-X","article-title":"Clinical pharmacology of sodium-butyrate in patients with acute-leukemia","volume":"23","author":"Miller","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0195","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1528-1167.2006.00846.x","article-title":"Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003","volume":"47","author":"Koenig","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/BF02722604","article-title":"Fatal cardiac malformation in fetal valproate syndrome","volume":"68","author":"Sodhi","year":"2001","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0215","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2125.1983.tb01541.x","article-title":"Trans-placental passage and half-life of sodium valproate in infants born to epileptic mothers","volume":"15","author":"Kaneko","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.410140107","article-title":"Plasma concentrations of sodium valproate \u2014 their clinical value","volume":"14","author":"Turnbull","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0225","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.31.4.486","article-title":"Human-brain, plasma, and cerebrospinal-fluid concentration of sodium valproate after 72hours of therapy","volume":"31","author":"Vajda","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0230","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.2042-7158.1992.tb03634.x","article-title":"Dose-dependent inhibition in plasma-protein binding of valproic acid during continued treatment in guinea-pigs","volume":"44","author":"Yu","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0235","doi-asserted-by":"crossref","first-page":"178-U2","DOI":"10.1038\/nature05772","article-title":"Recovery of learning and memory is associated with chromatin remodelling","volume":"447","author":"Fischer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2013.06.007_bb0240","doi-asserted-by":"crossref","first-page":"55-U8","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805113001224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:27:50Z","timestamp":1760848070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805113001224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0969805113001224"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.06.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2013.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}